Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Luigi Mangione Mugshot

Mangione charged with terrorism-related murder in UnitedHealthcare CEO killing

A grand jury in New York has indicted Luigi Mangione, 26, on 11 charges, including murder in the first degree. 

artificial intelligence AI healthcare regulation FDA

Healthcare AI regulation needs nuance, balance: Research review

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Elizabeth Warren

Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies

The Patients Before Monopolies Act, introduced in both the House and Senate, gives parent companies of PBMs three years to divest from pharmacies or face penalties. 

the words "FDA recall" on a board

FDA recalls 233K bottles of antidepressants due to cancer risk

Bottles of duloxetine manufactured by Rising Pharmaceuticals are being recalled due to higher-than-normal levels of nitrosamine contaminants. The recall is classified as Class II, the second most serious type.

Federal Trade Comission FTC Sign logo

FTC warns 21 health insurance brokers against deceptive tactics

The Federal Trade Commission did not accuse the companies of wrongdoing. However, it advised them to stay out of trouble by not deploying robocalls, impersonating the government or other common illegal marketing strategies. 

RBMA Board member Kit Crancer outlines the key legislation in radiology to watch.

Pending radiology bills in Congress and predicting the Trump administration's impact on imaging

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty. 

FDA Commissioner Robert Califf, MD, a cardiologist, speaking at the TCT interventional cardiology conference on health disparities in the U.S. health system and paying more for care has not resulted in better outcomes. #healthdisparities #healthequity

FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system

FDA Commissioner Robert Califf, MD, talked to Cardiovascular Business about healthcare spending, inconsistent patient outcomes and much more.

Displaying 9 - 16 of 3407

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.